Masitinib in nonresectable pancreatic cancer: Results of a phase III randomized placebo-controlled trial.
Gael Deplanque
No relevant relationships to disclose
Martin Demarchi
No relevant relationships to disclose
Mohamed Hebbar
No relevant relationships to disclose
Patrick J. Flynn
No relevant relationships to disclose
Bohuslav Melichar
No relevant relationships to disclose
James Atkins
No relevant relationships to disclose
Philippe Ruszniewski
No relevant relationships to disclose
Eric Raymond
Consultant or Advisory Role - Lilly
Research Funding - Lilly
Olivier Hermine
Employment or Leadership Position - AB Science
Stock Ownership - AB Science
Pascal Hammel
Consultant or Advisory Role - Novartis
Honoraria - Merck Serono; Pfizer